Low bone mass density and gynecological factors in climacteric women;Baja masa ósea y factores ginecológicos asociados en mujeres climatéricas

Revista Espanola de Enfermedades Metabolicas Oseas

Volumn 17, Issue 3, 2008, Pages 35-43

  Quiles Izquierdo, J ^a   Nohales Alfonso, F J ^b   Fullana Montoro, A M ^a   Castello J ^b   Carmona Moral, J V ^b  

^a Servicio de Salud Infantil Y de la Mujer   (Spain)

^b Hospital San Francesc de Borja   (Spain)

Author keywords

Age related; Low bone mass; Menopause; Osteoporosis; Prevalence; Woman's healh

Indexed keywords

ADULT; AGE DISTRIBUTION; AGED; ARTICLE; BONE DENSITY; BONE MASS; CONTROLLED STUDY; DUAL ENERGY X RAY ABSORPTIOMETRY; FEMALE; FEMALE FERTILITY; HUMAN; MAJOR CLINICAL STUDY; MENARCHE; OSTEOPENIA; OSTEOPOROSIS; PREVALENCE; SPAIN; WOMEN'S HEALTH;

EID: 44949254996     PISSN: 11328460     EISSN: 15781844     Source Type: Journal    
DOI: 10.1016/S1132-8460(08)71138-3     Document Type: Article

References (27)

1. Consensus Development Conference. Diagnosis, prophylaxis and treatment of osteoporosis. Am J Med. 1993;94:646-50.
2. Cumming SR, Meltem LS. Epidemiology and outcomes of OP fractures. Lancet. 2002;359:1761-4.
3. Marshall D, Johnell O, Wedel H. Meta-analysis of how well measures of bone mineral density predict ocurrente of osteoporotic fractures. BMJ. 1996;312:1254-9.
4. Yates AJ, Ross PD, Lydick E, Epstein RS. Radiographic absortiometry in the diagnosis of osteoporosis. Am J Med. 1995;98:41S-7S.
5. Pérez-Castrillón JL, Martín-Escudero JC, del Pino-Montes J, Blanco FS, Martín FJ, Paredes MG, et al. Prevalence of osteoporosis using DXA bone mineral density measuraments at the calcaneus: cut-off points of diagnosis and exclusion of osteoporosis. J Clin Densitom. 2005;8:404-8.
6. Díaz-Curiel M, García JJ, Carrasco JL, Honorato J, Pérez-Cano R, Rapado A, et al. Prevalencia de osteoporosis determinada por densitometría en la población femenina española. Med Clin (Barc). 2001;116:86-8.
7. Reyes Balaguer J, Moreno Olmos J. Prevalence of osteopenia and osteoporosis in postmenopausal women. Aten Primaria. 2005;35:342-7.
8. Johnell O, Kanis JA, Oden A, Johansson H, De Laet C, Delmas P, et al. Predictive value of BMD for hip and other fractures. J Bone Miner Res. 2005;20:1185-94.
9. Estrada MD, Ferrer A, Borràs A, Benítez D, Espallargues M. Guía per a la indicació de la densitometría òssia en la valoració del risc de fractura i en el control evolutiu de l'osteoporosi. Actualització desembre 2004. Barcelona: Agència d'Avaluació de Tecnología i Recerca Mèdiques. CatSalut. Departament de Salut. Generalitat de Catalunya. Febrer 2006 (GGPC01/2006).
10. Faulkner KG, Von Stetton E, Miller P. Discordance in patient classification using T scores. J Clin Densitom. 1999;2:343-50.
11. Lu Y, Genant HK, Shepherd J, Zhao S, Mathur A, Fuerst TP, et al. Classification of osteoporosis based on bone mineral densities. J Bone Miner Res. 2001;16:901-10.
12. Fordham JN, Chinn DJ, Kumar N. Identification of women with reduced bone density at the lumbar spine and femoral neck using BMD at the os calcis. Osteoporos Int. 2000;11:797-802.
13. Quiles J, Nohales J, Castelló J, Carmona JV, Mas J, Fullana A. Capacidad predictiva de la densitometría de calcáneo en mujeres climatéricas. REEMO. 2007;16:85-9.
14. Blake GM, Fogelman I. Role of dual-energy X-ray absorptiometry in the diagnosis and treatment of osteoporosis. J Clin Densitometry. 2007;10:102-10.
15. Kanis JA, Johnell O, Oden A, Johansson H, Eisman JA, Fujiwara S, et al. The use of multiple sites for the diagnosis of osteoporosis. Osteoporos Int. 2006;17:527-34.
16. Grupo de trabajo de la SEIOMM. Osteoporosis postmenopáusica. Guía práctica clínica. Rev Clin Esp. 2003;203:496-506.
17. Riggs BL, Kholsa S, Melton LJ III. A unitary model for involutional osteoporosis: oestrogen deficiency causes both type 1 and type 2 osteoporosis in postmenopausal women and contributes to bone loss in aging men. J Bon Miner Res. 1998;13:763-73.
18. Seeman E. Pathogenesis of bone fragility in women and men. Lancet. 2002;359:1841-50.
19. Roy DK, O'Neill TW, Finn JD, Luna M, Silman AJ, Felsenberg D, et al. Determinants of incident vertebral fracture in men and women: results from the European Prospective Osteoporosis Study (EPOS). Osteoporos Int. 2003;14:19-26.
20. Silman AJ. Risk factors for Colles' fracture in men and women: results from the European Prospective Osteoporosis Study. Osteoporos Int. 2003;14:213-8.
21. Hadji P, Ziller V, Kalder M, Gottschalk M, Hellmeyer L, Hars O, et al. Influence of pregnancy and breast-feeding on quantitative ultrasonometry of bone in postmenopausal women. Climacteric. 2002;5:277-85.
22. Rossouw JE, Anderson GL, Prentice RL, LaCroix AZ, Kooperberg C, Stefanick ML, et al. Risks and benefits of oestrogen plus progestin in healthy postmenopausal women: principal results From the Women's Health Initiative randomized controlled trial. JAMA. 2002;288:321-33.
23. Cauley JA, Robbins J, Chen Z, Cummings SR, Jackson RD, LaCroix AZ, et al. Effects of estrogen plus progestin on risk of fracture and bone mineral density: the Women's Health Initiative randomized trial. JAMA. 2003;290:1729-38.
24. Chlebowski RT, Hendrix SL, Langer RD, Stefanick ML, Gass M, Lane D, et al. Influence of estrogen plus progestin on breast cancer and mammography in healthy postmenopausal women: the Women's Health Initiative Randomized Trial. JAMA. 2003;289:3243-53.
25. Manson JE, Hsia J, Johnson KC, Rossouw JE, Assaf AR, Lasser NL, et al. Estrogen plus progestin and the risk of coronary heart disease. N Engl J Med. 2003;349:523-34.
26. Million Women Study. Breast cancer and hormona-replacement therapy in the Million Women Study. Lancet. 2003;362:419-27.
27. Conselleria de Sanitat de la Generalitat Valenciana. Plan de Prevención y Control de la Osteoporosis en la Comunidad Valenciana. Valencia: Conselleria de Sanitat; 2003.